Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Methyl-(S)-methyl-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate is used in the synthetic preparation of Vibegron which is potent and selective human β3 adrenergic receptor agonist for treatment of overactive bladder.